PT  - JOURNAL ARTICLE
AU  - Bojana Velichkovska
AU  - Hristijan Gjoreski
AU  - Daniel Denkovski
AU  - Marija Kalendar
AU  - Leo Anthnoy Celi
AU  - Venet Osmani
TI  - Investigating Presence of Ethnoracial Bias in Clinical Data using Machine Learning
AID  - 10.1101/2021.09.01.21262949
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.09.01.21262949
4099  - http://medrxiv.org/content/early/2021/09/03/2021.09.01.21262949.short
4100  - http://medrxiv.org/content/early/2021/09/03/2021.09.01.21262949.full
AB  - An important target for machine learning research is obtaining unbiased results, which require addressing bias that might be present in the data as well as the methodology. This is of utmost importance in medical applications of machine learning, where trained models should be unbiased so as to result in systems that are widely applicable, reliable and fair. Since bias can sometimes be introduced through the data itself, in this paper we investigate the presence of ethnoracial bias in patients’ clinical data. We focus primarily on vital signs and demographic information and classify patient ethnoraces in subsets of two from the three ethnoracial groups (African Americans, Caucasians, and Hispanics). Our results show that ethnorace can be identified in two out of three patients, setting the initial base for further investigation of the complex issue of ehtnoracial bias.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBV, HG, DD, MK, VO are funded by the European Commission, Horizon 2020 programme, under grant 952279. LAC is funded by the National Institute of Health through NIBIB R01 EB017205.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The analysis using the eICU-CRD is exempt from institutional review board approval due to the retrospective design, lack of direct patient intervention, and the security schema, for which the re-identification risk was certified as meeting safe harbor standards by an independent privacy expert (Privacert, Cambridge, MA) (Health Insurance Portability and Accountability Act Certification no. 1031219-2). All experiments were performed in accordance with relevant guidelines and regulations.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets analyzed in the current study are publicly available in the eICU-CRD repository. https://eicu-crd.mit.edu/